Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.
about
Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophiliaCorrelation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilitiesResistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.The inactivation of RNase G reduces the Stenotrophomonas maltophilia susceptibility to quinolones by triggering the heat shock responseEfflux-mediated antimicrobial resistance.Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia.Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, CaliforniaDynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains.Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of the multidrug efflux pump SmeDEF.Draft Genome Sequences of Two Drug-Resistant Isolates of Pseudomonas aeruginosa Obtained from Keratitis Patients in India.Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains.Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea.Riemerella anatipestifer M949_0459 gene is responsible for the bacterial resistance to tigecycline.Mechanism of action of and resistance to quinolones
P2860
Q26801653-1D2D252D-1594-442B-8E19-6A5D635CAE8AQ33807598-11410A1F-6850-48D8-BF1D-9332195A32FFQ35066715-E9248E48-54C0-4DAA-8D5E-71739F3795ECQ35681397-20A6F977-769E-45EB-8609-ABBAB776480EQ35833140-5ED547C0-331E-42F9-BAE2-C88017269587Q36138147-6F659F89-584E-49A9-81B1-68F7776743DDQ36158458-AA59962B-267B-4011-9141-B2345A4A0355Q36845404-62D62A89-AFB3-4548-B1AC-C45B912FC762Q37421041-6257D03E-5E6D-4278-A7BB-E51B8F8C6AB9Q40621865-62E417DD-33B2-4B46-A486-5278AB0B9143Q40882563-50D21BB5-F62B-4978-9363-9E84E40A0ED5Q43101882-5F4B3C8D-718E-421F-9922-AEA28DB9D581Q46520778-9CF73E13-E391-46AC-8371-365A1E388E2EQ46610974-0AD95DD3-312C-4BA6-A131-5F91ED819AD1Q47145775-02668F33-B6DF-4D9B-AA50-BE73C9201227Q58057075-D9BE9CA0-B286-4AF3-8FD4-BCCA64D0FAA1
P2860
Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Topoisomerase II and IV quinol ...... s of quinolone susceptibility.
@en
Topoisomerase II and IV quinol ...... s of quinolone susceptibility.
@nl
type
label
Topoisomerase II and IV quinol ...... s of quinolone susceptibility.
@en
Topoisomerase II and IV quinol ...... s of quinolone susceptibility.
@nl
prefLabel
Topoisomerase II and IV quinol ...... s of quinolone susceptibility.
@en
Topoisomerase II and IV quinol ...... s of quinolone susceptibility.
@nl
P2093
P2860
P1476
Topoisomerase II and IV quinol ...... s of quinolone susceptibility.
@en
P2093
Ana Vindel
Aurora Echeita
Fernando Baquero
Rafael Cantó
Sylvia Valdezate
P2860
P304
P356
10.1128/AAC.46.3.665-671.2002
P407
P577
2002-03-01T00:00:00Z